AtriCure's Stock Rises After Launch of cryoSPHERE MAX Device [Yahoo! Finance]
AtriCure, Inc. (ATRC)
Last atricure, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.atricure.com
Company Research
Source: Yahoo! Finance
AtriCure, Inc. ( ATRC has launched the cryoSPHERE MAX cryoablation probe, which enhances Cryo Nerve Block (cryoNB) therapy by reducing freeze times by 50% compared to previous models and over 30% when compared to the cryoSPHERE+ probe cryoNB therapy, using AtriCure's cryoICE technology, is a non-pharmacological method to freeze targeted intercostal nerves, providing temporary pain relief along peripheral nerve pathways. The cryoSPHERE MAX device, part of AtriCure's cryoNB therapy, cuts ablation time by 50% per nerve, reducing it to 60 seconds. Featuring a larger 10 mm ball tip improves tissue coverage, heat extraction and operational efficiency, allowing faster and more effective post-operative pain management with better nitrous oxide gas usage, tactile feedback and real-time temperature monitoring. Likely Trend of ATRC Stock Following the News Following the news, shares of ATRC rose 3.6% to $28.61 at yesterday's closing. Shares of ATRC have plunged 19.9% year to date agai
Show less
Read more
Impact Snapshot
Event Time:
ATRC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATRC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATRC alerts
High impacting AtriCure, Inc. news events
Weekly update
A roundup of the hottest topics
ATRC
News
- AtriCure to Participate in the Piper Sandler 36th Annual Healthcare ConferenceBusiness Wire
- AtriCure to Participate in the Stifel 2024 Healthcare ConferenceBusiness Wire
- US$42.67 - That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results [Yahoo! Finance]Yahoo! Finance
- AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Canaccord Genuity Group Inc. from $49.00 to $53.00. They now have a "buy" rating on the stock.MarketBeat
- AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Oppenheimer Holdings Inc. from $32.00 to $36.00. They now have an "outperform" rating on the stock.MarketBeat
ATRC
Earnings
- 10/29/24 - Beat
ATRC
Sec Filings
- 11/14/24 - Form SC
- 11/12/24 - Form SCHEDULE
- 10/30/24 - Form 10-Q
- ATRC's page on the SEC website